Page last updated: 2024-09-03

zk 112993 and 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione

zk 112993 has been researched along with 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione in 1 studies

Compound Research Comparison

Studies (zk 112993)	Trials (zk 112993)	Recent Studies (post-2010) (zk 112993)	Studies (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione)	Trials (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione)	Recent Studies (post-2010) (16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione)
25	0	0	116	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borras, M; Lacroix, M; Leclercq, G; Legros, N	1

Other Studies

1 other study(ies) available for zk 112993 and 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione

Article	Year
Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar phenotype of breast cancers. Cancer letters, 1997, Nov-25, Volume: 120, Issue:1 Topics: Breast Neoplasms; Cell Division; Cytosol; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gonanes; Hormone Antagonists; Humans; Mifepristone; Pregnenediones; Progestins; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured	1997

Article

Year

Estrogen receptor-negative/progesterone receptor-positive Evsa-T mammary tumor cells: a model for assessing the biological property of this peculiar phenotype of breast cancers.

Cancer letters, 1997, Nov-25, Volume: 120, Issue:1

Topics: Breast Neoplasms; Cell Division; Cytosol; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Gonanes; Hormone Antagonists; Humans; Mifepristone; Pregnenediones; Progestins; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured

1997